JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, cilt.10, sa.1, ss.73-78, 2014 (SCI-Expanded)
Background: Synovial sarcoma (SS) is a rare disease and compared with other soft-tissue sarcomas has a relatively high mortality rate. The optimal management of this disease and prognostic factors associated with patient outcome remains controversial.